
Kif15-IN-1
CAS No. 672926-32-8
Kif15-IN-1( KIF15-IN-1 | KIF15IN-1 | KIF15-IN1 | KIF15IN1 | KIF15 IN 1 )
Catalog No. M15567 CAS No. 672926-32-8
Kif15-IN-1 is a potent, selective inhibitor of KIF15 motility, can act synergistically with Eg5 inhibitors to impair cancer cell proliferation.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 312 | Get Quote |
![]() ![]() |
50MG | 1341 | Get Quote |
![]() ![]() |
100MG | 1791 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameKif15-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionKif15-IN-1 is a potent, selective inhibitor of KIF15 motility, can act synergistically with Eg5 inhibitors to impair cancer cell proliferation.
-
DescriptionKif15-IN-1 is a potent, selective inhibitor of KIF15 motility, can act synergistically with Eg5 inhibitors to impair cancer cell proliferation.
-
In Vitro——
-
In Vivo——
-
SynonymsKIF15-IN-1 | KIF15IN-1 | KIF15-IN1 | KIF15IN1 | KIF15 IN 1
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetKinesin
-
RecptorKinesin
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number672926-32-8
-
Formula Weight430.479
-
Molecular FormulaC20H22N4O5S
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 100 mg/mL 232.30 mM; H2O : < 0.1 mg/mL
-
SMILESO=C(C1=C(C)N=C(NC([C@@H](N2C(NC3=C(C=CC=C3)C2=O)=O)C(C)C)=O)S1)OCC
-
Chemical Nameethyl (S)-2-(2-(2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl)-3-methylbutanamido)-4-methylthiazole-5-carboxylate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Preparation of quinazolinediones as Kif15 kinesin inhibitors for treating cellular proliferative disorders. Pat. Appl. Publ. (2004), US 20040053948 A1 20040318.
2. Milic B, et al. Proc Natl Acad Sci U S A. 2018 Apr 27. pii: 201801242.
molnova catalog



related products
-
TCS-OX2-29
TCS-OX2-29 is a potent and selective OX2 receptor antagonist (IC50: 40 nM). It displays >250-fold selectivity for OX2 over OX1.
-
PF-2771
PF-2771 is a potent, selective CENP-E inhibitor with IC50 of 16.1 nM.
-
Propofol
A widely used general anesthetic to induce and maintain anesthesia; influences ligand-gated channels.